The Evolution of Virtual Care in Respirology

By HEOR Staff Writer

September 13, 2023

The escalating prevalence of chronic diseases coupled with an ageing population is leading to a significant surge in demand for continuous home and institutional care. With professional resources in Québec becoming increasingly limited, virtual care tools have emerged as a crucial solution to ensure access to care and services.

The COVID-19 pandemic has accelerated the use of virtual care tools, promoting continuity of care when in-person visits became risky or impossible. These tools, ranging from telemonitoring to teleconsultation, are becoming integral to the evaluation, treatment, and follow-up of patients in specialty medicine, including respirology.

Virtual Care Modalities in Respirology

Primarily, virtual care modalities are being used to improve access to health care and foster patient engagement in managing their illness. For instance, telemonitoring is the most studied intervention in all the care pathways examined, with a positive impact reported in patients with COPD (Chronic Obstructive Pulmonary Disease) and asthma. Telemonitoring, the most studied intervention, has shown positive effects in COPD and asthma patients. 


The potential of virtual care is vast. It can reduce symptoms of disease, decrease anxiety, improve disease management, and enhance the quality of life for patients. Furthermore, it can support primary care physicians in diagnosing diseases like COPD and asthma, thereby preventing misdiagnosis.

Challenges and Future Directions

Despite the promising results, there is a need for more high-quality studies to further explore the efficacy of virtual care interventions. Areas that need further investigation include the long-term efficacy of virtual care in terms of medication adherence and the use of virtual care for diseases like cystic fibrosis and chronic respiratory failure.

In conclusion, the most studied care pathway for the use of virtual care in respirology is for COPD, with telemonitoring being the most frequently used modality. As we continue to navigate the digital health landscape, the revolution of the respirology field is set to occur through the integration of virtual care modalities into care pathways.

Reference url

Recent Posts

NICE Approves Durvalumab for Gastric Cancer Treatment

By HEOR Staff Writer

May 15, 2026

NICE has issued final draft guidance recommending durvalumab, within its marketing authorisation, for use with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy as neoadjuvant and adjuvant treatment, followed by durvalumab monotherapy as adjuvant treatment, in adults with ...
Marstacimab Cost-Effectiveness Analysis in Hemophilia Treatment: A Portuguese Assessment

By HEOR Staff Writer

May 12, 2026

The public assessment report for Hympavzi (marstacimab) in Portugal concludes that the product offers no added therapeutic value relative to recombinant factor VIII concentrates and emicizumab in patients aged 12 years and older weighing at least 35 kg with severe hemophilia A without factor VIII...
Overcoming Challenges in Managed Entry Agreements for ATMPs
Decision-makers in England, the Netherlands, and Spain consistently identify administrative burden, outcome measurement, and data collection as the foremost obstacles to adopting managed entry agreements ATMPs. These challenges emerge most acutely when hybrid or outcome-based agreements are consi...